for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioNTech SE - ADR

22UAy.DE

Latest Trade

254.30EUR

Change

-21.00(-7.63%)

Volume

218,857

Today's Range

251.10

 - 

267.60

52 Week Range

65.50

 - 

395.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
275.30
Open
266.50
Volume
218,857
3M AVG Volume
88.04
Today's High
267.60
Today's Low
251.10
52 Week High
395.00
52 Week Low
65.50
Shares Out (MIL)
241.52
Market Cap (MIL)
80,874.55
Forward P/E
8.18
Dividend (Yield %)
--

Next Event

Q3 2021 BioNTech SE Earnings Release

Latest Developments

更多

CDC Statement On ACIP Booster Recommendations

FDA Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Certain Populations

Pfizer Inc And Biontech Expand Collaboration With U.S. To Provide Covid-19 Vaccine Doses At Not-For-Profit Price For Donation To Poorest Countries

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BioNTech SE - ADR

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Industry

Biotechnology & Drugs

Contact Info

An der Goldgrube 12

55131

Germany

+49.6131.90840

https://biontech.de/

Key Stats

2.50 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2019

0.1K

2020

0.5K

2021(E)

16.6K
EPS (EUR)

2019

-0.850

2020

0.060

2021(E)

34.798
Price To Earnings (TTM)
17.42
Price To Sales (TTM)
8.89
Price To Book (MRQ)
12.54
Price To Cash Flow (TTM)
16.75
Total Debt To Equity (MRQ)
21.87
LT Debt To Equity (MRQ)
8.87
Return on Investment (TTM)
120.65
Return on Equity (TTM)
80.46

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up